GSK-3 – at the crossroads of cell death and survival
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Glycogen synthase kinase 3 (GSK-3) is involved in various signaling pathways controlling metabolism, differentiation and immunity, as well as cell death and survival. GSK-3 targets transcription factors, regulates the activity of metabolic and signaling enzymes, and controls the half-life of proteins by earmarking them for degradation. GSK-3 is unique in its mode of substrate recognition and the regulation of its kinase activity, which is repressed by pro-survival phosphoinositide 3-kinase (PI3K)–AKT signaling. In turn, GSK-3 exhibits pro-apoptotic functions when the PI3K–AKT pathway is inactive. Nevertheless, as GSK-3 is crucially involved in many signaling pathways, its role in cell death regulation is not uniform, and in some situations it promotes cell survival. In this Commentary, we focus on the various aspects of GSK-3 in the regulation of cell death and survival. We discuss the effects of GSK-3 on the regulation of proteins of the BCL-2 family, through which GSK-3 exhibits pro-apoptotic activity. We also highlight the pro-survival activities of GSK-3, which are observed in the context of nuclear factor κB (NFκB) signaling, and we discuss how GSK-3, by impacting on cell death and survival, might play a role in diseases such as cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., & Greenberg, M. E. (1997) · Cell · doi:10.1016/s0092-8674(00)80405-5 · Cited by 5,689
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
MacDonald, B. T., Tamai, K., & He, X. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.06.016 · Cited by 5,583
Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244 · cited 2×
“When AKT is activated, it phosphorylates the two isoforms of GSK-3 (Cross et al., 1995) on their N-terminus; in the case of GSK-3a, position S21 is targeted, whereas GSK-3b is phosphorylated at position S9.”
BackgroundThe ground state of embryonic stem cell self-renewal
Ying, Q.-L., Wray, J., Nichols, J., Batlle-Morera, L., Doble, B., Woodgett, J., Cohen, P., & Smith, A. (2008) · Nature · doi:10.1038/nature06968 · Cited by 3,442 · cited 3×
“Besides its early-identified role in metabolism, GSK-3 has a number of additional biological functions, including in stem cell renewal (Ying et al., 2008) and embryonic development”
BackgroundInfluentialRegulation of neuronal survival by the serine-threonine protein kinase Akt
Dudek, H., Datta, S. R., Franke, T. F., Birnbaum, M. J., Yao, R., Cooper, G. M., Segal, R. A., Kaplan, D. R., & Greenberg, M. E. (1997) · Science · doi:10.1126/science.275.5300.661 · Cited by 2,436 · cited 2×
“of cerebellar neurons, an effect that is compromised when inactive AKT mutants are expressed in these cells (Dudek et al., 1997).”
BackgroundPI3K pathway alterations in cancer: variations on a theme
Yuan, T. L., & Cantley, L. C. (2008) · Oncogene · doi:10.1038/onc.2008.245 · Cited by 1,845
Zhou, B. P., Deng, J., Xia, W., Xu, J., Li, Y. M., Gunduz, M., & Hung, M.-C. (2004) · Nature Cell Biology · doi:10.1038/ncb1173 · Cited by 1,581 · cited 1×
“…and/or -7 Initiator caspase Effector caspase Apoptosis FADD FADD Bak Bax GSK-3 active Jo ur na l o f C el l S ci en ce Snail, a transcription factor involved in epithelial–mesenchymal transition (EMT) is also marked for degradation by SCFb-TRCP upon phosphorylation by GSK-3 (Zhou et al., 2004).”
Backgroundp53- and Drug-Induced Apoptotic Responses Mediated by BH3-Only Proteins Puma and Noxa
Villunger, A., Michalak, E. M., Coultas, L., Müllauer, F., Böck, G., Ausserlechner, M. J., Adams, J. M., & Strasser, A. (2003) · Science · doi:10.1126/science.1090072 · Cited by 1,327
The apoptosome: Signalling platform of cell death
Riedl, S. J., & Salvesen, G. S. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2153 · Cited by 1,097 · cited 2×
“…such as nuclear condensation, oligonucleosomal DNA cleavage, phosphatidylserine exposure and the shut-off of respiration, resulting in cell death and immediate uptake of apoptotic cells by phagocytes, in general without triggering inflammation (Martin et al., 2012; Riedl and Salvesen, 2007) .”
BackgroundWelcker, M., & Clurman, B. E. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2290 · Cited by 1,084 · cited 2×
“It has been suggested that a GSK-3-induced phosphodegron might actually be common to all SCF substrates (Welcker and Clurman, 2008).”
BackgroundMaurer, U., Charvet, C., Wagman, A. S., Dejardin, E., & Green, D. R. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.02.009 · Cited by 881 · cited 10×
“In our study, GSK-3 activity was triggered by growth factor withdrawal, but direct inhibition of PI3K also resulted in the loss of Mcl-1 (Maurer et al., 2006), as also reported by Hung and colleagues (Ding et al., 2007).”
BackgroundResultInfluentialSelf-citationIAPs: from caspase inhibitors to modulators of NF-κB, inflammation and cancer
Gyrd-Hansen, M., & Meier, P. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2889 · Cited by 790 · cited 3×
“…cIAP proteins are E3 ubiquitin ligases that promote survival through K63linked ubiquitylation of constituents of TNFR complex I, such as RIPK1 (Gyrd-Hansen and Meier, 2010). c-FLIP, a close relative of caspase-8 without enzymatic activity, prevents proapoptotic homodimeric activation of…”
BackgroundAcetylation of the p53 DNA-binding domain regulates apoptosis induction.
Sykes, S. M., Mellert, H. S., Holbert, M. A., Li, K., Marmorstein, R., Lane, W. S., & McMahon, S. B. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.11.026 · Cited by 752 · cited 1×
“The p53-mediated transcriptional induction of Puma, but not of p21, has been shown previously to require lysine acetylation of p53 at position K120, mediated by the acetyltransferase Tip60 (also known as KAT5) (Sykes et al., 2006; Tang et al., 2006).”
BackgroundRing, D. B., Johnson, K. W., Henriksen, E. J., Nuss, J. M., Goff, D., Kinnick, T. R., Ma, S. T., Reeder, J. W., Samuels, I., Slabiak, T., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.3.588 · Cited by 532 · cited 1×
“We found that the rate of cell death owing to IL-3 withdrawal is profoundly reduced upon inhibition of GSK-3 with the small-molecule inhibitors CT98014 or CT99021, inhibitors that exhibit high potency and specificity in the nanomolar range (Bain et al., 2007; Ring et al., 2003).”
BackgroundPhosphorylation by p38 MAPK as an Alternative Pathway for GSK3β Inactivation
Thornton, T. M., Pedraza-Alva, G., Deng, B., Wood, C. D., Aronshtam, A., Clements, J. L., Sabio, G., Davis, R. J., Matthews, D. E., Doble, B., et al. (2008) · Science · doi:10.1126/science.1156037 · Cited by 484 · cited 7×
“However, in contrast to MAPKs, the activating tyrosine phosphorylation of GSK-3 occurs by autophosphorylation (Cole et al., 2004).”
BackgroundInfluentialDomina, A. M., Vrana, J. A., Gregory, M. A., Hann, S. R., & Craig, R. W. (2004) · Oncogene · doi:10.1038/sj.onc.1207692 · Cited by 327 · cited 2×
“Intriguingly, ERK-mediated phosphorylation of T163 (the GSK-3-priming site in human Mcl-1) results in Mcl-1 stabilization (Domina et al., 2004) in a”
BackgroundWelsh, G. I., Miller, C. M., Loughlin, A. J., & Price, N. T. (1998) · FEBS Letters · doi:10.1016/s0014-5793(97)01548-2 · Cited by 298 · cited 2×
“Protein translation is also repressed by GSK-3 through an inhibition of the activity of the eukaryotic initiation factor eIF2B (Welsh et al., 1998).”
BackgroundGlycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy
Wang, Z., Smith, K. S., Murphy, M., Piloto, O., Somervaille, T. C. P., & Cleary, M. L. (2008) · Nature · doi:10.1038/nature07284 · Cited by 265 · cited 2×
“In this context, GSK-3 has been shown to be required for maintaining the transformation state of MLL, which could be prevented by loss or inhibition of GSK-3, and, interestingly, also by activation of AKT (Wang et al., 2008).”
BackgroundThe ‘complexities’ of life and death: Death receptor signalling platforms
Dickens, L. S., Powley, I. R., Hughes, M. A., & MacFarlane, M. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.04.005 · Cited by 208 · cited 3×
“apoptotic homodimeric activation of caspase-8 by heterodimerizing with caspase-8 (Dickens et al., 2012).”
BackgroundInfluentialMcl-1 Integrates the Opposing Actions of Signaling Pathways That Mediate Survival and Apoptosis
Morel, C., Carlson, S. M., White, F. M., & Davis, R. J. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00279-09 · Cited by 143 · cited 5×
“Indeed, we and others observed a similar mechanism by which Mcl-1 is destabilized upon phosphorylation by GSK-3 (Ding et al., 2007; Inuzuka et al., 2011; Maurer et al., 2006; Morel et al., 2009; Zhao et al., 2007).”
BackgroundInfluentialGlycogen synthase kinase 3-dependent phosphorylation of Mdm2 regulates p53 abundance
Kulikov, R., Boehme, K. A., & Blattner, C. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.16.7170-7180.2005 · Cited by 132 · cited 2×
“In that report, GSK-3 was shown to directly phosphorylate and activate the p53-degrading E3 ligase MDM2, so that c-irradiation, and thus GSK-3 inactivation, resulted in the stabilization of p53 (Kulikov et al., 2005).”
Background
Cited by
Metabolic features and regulation in cell senescence
Kwon, S. M., Hong, S. M., Lee, Y.-K., Min, S., & Yoon, G. (2019) · BMB Reports · doi:10.5483/bmbrep.2019.52.1.291 · Cited by 111
“eIF2B (88), and activates autophagy via the TIP60/ULK axis (89).”
BackgroundHirano, M., Imai, Y., Kaito, Y., Murayama, T., Sato, K., Ishida, T., Yamamoto, J., Ito, T., Futami, M., Ri, M., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01909-7 · Cited by 25
Hudson, R., Green, M., Wright, D. J., Renard, J., Jobson, C. E. L., Jung, T., Rushlow, W., & Laviolette, S. R. (2021) · Addiction Biology · doi:10.1111/adb.12891 · Cited by 23
Metadata
- Authors
- Maurer, U., Preiss, F., Brauns-Schubert, P., Schlicher, L., & Charvet, C.
- Venue
- Journal of Cell Science
- Publisher
- The Company of Biologists
- Published
- 2014-04-01
- Volume
- 127
- Issue
- 7
- Pages
- 1369-1378
- ISSN
- 0021-9533 (ISSN-L)
- 1477-9137
- OpenAlex
- W2057042766
- Cited by
- 188
- References
- 21
- FWCI
- 4.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.